Stem Cell Agency Finance Subcommittee Meeting December 3, 2010
Stem Cell Agency Finance Subcommittee Meeting
MEETING NOTICE AND AGENDA
OF THE INDEPENDENT CITIZENS OVERSIGHT COMMITTEE
TO THE CALIFORNIA INSTITUTE FOR REGENERATIVE MEDICINE
Organized Pursuant to the
CALIFORNIA STEM CELL RESEARCH AND CURES ACT
1. Call to Order.
2. Roll Call.
[Members of the Public will be invited to provide testimony before or during consideration of each agenda item. Speakers are asked to limit their testimony to three (3) minutes.]
3. Consideration of risk premium options for loan programs, including amendments to warrant coverage requirements in Loan Administration Policy and adoption of interim regulations to offer payback of multiple of loan amount as alternative to warrant coverage.
4. Discussion regarding bond market and future implications for CIRM.
5. Public Comment.
The California Institute for Regenerative Medicine and its Independent Citizen’s Oversight Committee, and any subcommittees thereof, comply with the Americans with Disabilities Act (ADA) by ensuring that the meeting facilities are accessible to persons with disabilities, and providing that this notice and information given to the Members of the Committee is available to the public in appropriate alternative formats when requested. If you need further assistance, including disability-related modifications or accommodations, you may contact Melissa King at the California Institute for Regenerative Medicine at 415-396-9100 no later than the day prior to the meeting.
Questions or requests for additional information prior to the Independent Citizen’s Oversight Committee meeting may be referred to Melissa King at the California Institute for Regenerative Medicine at email@example.com or 415-396-9100.
This meeting agenda is also available on the website for the California Institute for Regenerative Medicine at https://www.cirm.ca.gov
Last Modified: April 5, 2017